Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Cancer Stem Cells in Colorectal Cancer: Implications for Targeted Immunotherapies Publisher Pubmed



Jalil AT1 ; Abdulhadi MA2 ; Al Jawadri AMH3 ; Talib HA4 ; Alazzawi AKJ5 ; Zabibah RS6 ; Ali A7
Authors
Show Affiliations
Authors Affiliations
  1. 1. Medical Laboratories Techniques Department, Al-Mustaqbal University College, Babylon, Hilla, 51001, Iraq
  2. 2. Department of Biochemistry, Faculty of Medicine, Anbar University, Anbar, Iraq
  3. 3. Department of Pharmaceutics Biomaterials, College of Pharmacy, Tehran University of Medical Science, Tehran, Iran
  4. 4. College of Agriculture, National University of Science and Technology, Dhi Qar, Iraq
  5. 5. Dentistry Department, Al-Turath University College, Baghdad, Iraq
  6. 6. Medical Laboratory Technology Department, College of Medical Technology, The Islamic University, Najaf, Iraq
  7. 7. Medical Technical College, Al-Farahidi University, Baghdad, Iraq

Source: Journal of Gastrointestinal Cancer Published:2023


Abstract

Purpose: Colorectal cancers are composed of heterogeneous cell populations in the concepts of genetic and functional degrees that among them cancer stem cells are identified with their self-renewal and stemness capability mediating primary tumorigenesis, metastasize, therapeutic resistance, and tumor recurrence. Therefore, understanding the key mechanisms of stemness in colorectal cancer stem cells (CRCSCs) provides opportunities to discover new treatments or improve existing therapeutic regimens. Methods: We review the biological significance of stemness and the results of potential CRCSC-based targeted immunotherapies. Then, we pointed out the barriers to targeting CRCSCs in vivo and highlight new strategies based on synthetic and biogenic nanocarriers for the development of future anti-CRCSC trials. Results: The CSCs’ surface markers, antigens, neoantigens, and signaling pathways supportive CRCSCs or immune cells that are interacted with CRCSCs could be targeted by immune monotherapy or in formulation with developed nanocarriers to overcome the resistant mechanisms in immune evader CRCSCs. Conclusion: Identification molecular and cellular cues supporting stemness in CRCSCs and their targeting by nanoimmunotherpy can improve the efficacy of existed therapies or explore novel therapeutic options in future. © 2023, The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
Related Docs
View other Related Docs
1. Update on Immune-Based Therapy Strategies Targeting Cancer Stem Cells, Cancer Medicine (2023)
2. The Role of the Natural Killer (Nk) Cell Modulation in Breast Cancer Incidence and Progress, Molecular Biology Reports (2022)
3. Transplantation Immune Responses: Biology, Challenges, and Opportunities Using Biomaterials, Gene Reports (2023)
4. Efficacy of Whole Cancer Stem Cell-Based Vaccines: A Systematic Review of Preclinical and Clinical Studies, Stem Cells (2023)
5. Deciphering Biological Characteristics of Tumorigenic Subpopulations in Human Colorectal Cancer Reveals Cellular Plasticity, Journal of Research in Medical Sciences (2016)
6. Dendritic Cell Based Immunotherapy Using Tumor Stem Cells Mediates Potent Antitumor Immune Responses, Cancer Letters (2016)
7. Improvement of Current Immunotherapies With Engineered Oncolytic Viruses That Target Cancer Stem Cells, Cell Biochemistry and Function (2024)
8. Cancer Stem Cell Research in Iran: Potentials and Challenges, Future Oncology (2017)
Experts (# of related papers)
View all Related Experts
Nima Rezaei (3)
Fatemeh Nili Ahmadabadi (1)
Other Related Docs
9. Preclinical Studies of Chimeric Antigen Receptor-Modified Natural Killer Cells in Cancer Immunotherapy: A Review, Expert Opinion on Biological Therapy (2022)
10. The Prediction of Dll4 As a Prognostic Biomarker in Patients With Gastric Cancer Using Anti-Dll4 Nanobody, Journal of Gastrointestinal Cancer (2024)
11. Applications of Innovation Technologies for Personalized Cancer Medicine: Stem Cells and Gene-Editing Tools, ACS Pharmacology and Translational Science (2023)
12. A New Insight Into Cancer Stem Cell Markers: Could Local and Circulating Cancer Stem Cell Markers Correlate in Colorectal Cancer?, Tumor Biology (2016)
13. Verification of Aldh Activity As a Biomarker in Colon Cancer Stem Cells-Derived Ht-29 Cell Line, International Journal of Cancer Management (2015)
14. Clinicopathological Significance of Tumor Stem Cell Markers Aldh1 and Cd133 in Colorectal Carcinoma, Iranian Journal of Pathology (2021)
15. Cell-Based Vaccines: Frontiers in Medical Technology for Cancer Treatment, Regenerative Engineering and Translational Medicine (2024)
16. Nano-Delivery System Targeting to Cancer Stem Cell Cluster of Differentiation Biomarkers, Journal of Controlled Release (2017)
17. Role of Tumor Microenvironment in Cancer Stem Cells Resistance to Radiotherapy, Current Cancer Drug Targets (2022)
18. Recent Progress in Cancer Immunotherapy: Overview of Current Status and Challenges, Pathology Research and Practice (2023)
19. Tumor Immunology, Clinical Immunology (2022)
20. Expression Patterns for Tets, Lgr5 and Bmi1 in Cancer Stem-Like Cells Isolated From Human Colon Cancer, Avicenna Journal of Medical Biotechnology (2019)
21. The Multifaceted Role of Extracellular Vesicles (Evs) in Colorectal Cancer: Metastasis, Immune Suppression, Therapy Resistance, and Autophagy Crosstalk, Journal of Translational Medicine (2024)
22. Oncolytic Virotherapy Improves Immunotherapies Targeting Cancer Stemness in Glioblastoma, Biochimica et Biophysica Acta - General Subjects (2024)
23. Glance Into Cancer Stem Cells, Journal of Kerman University of Medical Sciences (2016)
24. The Therapeutic Effect of Exosomes From Mesenchymal Stem Cells on Colorectal Cancer: Toward Cell-Free Therapy, Pathology Research and Practice (2022)
25. Car-Nk Cell: A New Paradigm in Tumor Immunotherapy, Frontiers in Oncology (2021)
26. Nano-Particles’ Benefits for Colon Cancer Effective Therapy: A Review of Recent Advancements and Clinical Trials, International Journal of Polymeric Materials and Polymeric Biomaterials (2024)
27. Epigenetic of Retinoic Acid Receptor ß2 Gene in Breast Cancer, Epigenetics Territory and Cancer (2015)
28. Macrophage’S Role in Solid Tumors: Two Edges of a Sword, Cancer Cell International (2023)
29. Potential Theranostics of Circulating Tumor Cells and Tumor-Derived Exosomes Application in Colorectal Cancer, Cancer Cell International (2020)